dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ramo-Tello, Cristina |
dc.contributor.author | Blanco, Yolanda |
dc.contributor.author | Brieva Ruiz, Luis |
dc.contributor.author | Casanova, Bonaventura |
dc.contributor.author | Martínez Cáceres, Eva |
dc.contributor.author | Ontaneda, Daniel |
dc.contributor.author | Rovira Cañellas, Alex |
dc.date.accessioned | 2022-02-25T13:00:02Z |
dc.date.available | 2022-02-25T13:00:02Z |
dc.date.issued | 2022-01 |
dc.identifier.citation | Ramo-Tello C, Blanco Y, Brieva L, Casanova B, Martínez-Cáceres E, Ontaneda D, et al. Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses. J Pers Med. 2022 Jan;12:6. |
dc.identifier.issn | 2075-4426 |
dc.identifier.uri | https://hdl.handle.net/11351/7084 |
dc.description | Metilprednisolona; Esclerosi múltiple; Recaiguda |
dc.description.sponsorship | This research was funded by NOVARTIS FARMACÉUTICA, SA, for the two expert panel meetings held and the recording and transcription of the content of the first meeting performed by the contract research organization, Dynamic. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Personalized Medicine;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject | Esclerosi múltiple - Diagnòstic |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Multiple Sclerosis, Relapsing-Remitting |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Quality of Health Care |
dc.title | Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jpm12010006 |
dc.subject.decs | esclerosis múltiple recurrente-remitente |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | calidad de la atención sanitaria |
dc.relation.publishversion | https://doi.org/10.3390/jpm12010006 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ramo-Tello C] Multiple Sclerosis and Clinical Neuroimmunology Unit, Germans Trias University Hospital, 08916 Badalona, Spain. [Blanco Y] Multiple Sclerosis Unit, Clínic Hospital, 08036 Barcelona, Spain. [Brieva L] Multiple Sclerosis Unit, IRBLLEIDA. Arnau de Vilanova Hospital, 25198 Lleida, Spain. [Casanova B] Multiple Sclerosis and Clinical Neuroimmunology Unit, La Fe Hospital, 46026 Valencia, Spain. [Martínez-Cáceres E] Immunology Service, LCMN, Germans Trias University Hospital, 08916 Badalona, Spain. [Ontaneda D] Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH 44195, USA. [Rovira À] Unitat de Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35055321 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |